AOP ORPHAN PHARMACEUTICALS
AOP Orphan Pharmaceuticals engages in developing, marketing, and distributing medicines for orphan indications and complex diseases.
AOP ORPHAN PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Medical Pharmaceutical
Founded:
1996-01-01
Address:
Vienna, Wien, Austria
Country:
Austria
Website Url:
http://www.aoporphan.com
Total Employee:
51+
Status:
Active
Contact:
+43 1 5037244
Email Addresses:
[email protected]
Technology used in webpage:
Smart App Banner Google No Translate Materialize CSS 10 To 14 CcTLD Redirects
Similar Organizations
AIDA Pharmaceuticals
AiDA Pharmaceuticals engages in the development, production and distribution of antibiotics, cardiovascular, and anti-cancer drugs.
Aplagon
Aplagon is committed to bringing unique, effective antithrombotic medicines with important safety advantages to patients with unmet needs.
Aquila BioMedical
Aquila BioMedical is a pre-clinical contract research company with expertise in immuno-oncology, immunology and multiplex histology.
Biomapas
Biomapas provides Clinical Trials, Regulatory Affairs, Medical Writing, and Pharmacovigilance services.
C-PHARM
C-PHARM is a distributor for medical supplies and equipment striving to supply the world with everything needed.
C3 Biotechnologies
C3 Biotechnologies is the development, commercialisation of an economically-sustainable manufacturing process for production of bio-propane.
Ciliatech
Ciliatech is the research, development, production, acquisition and distribution of pharmaceutical and diagnostic products and technologies.
CLL Pharma S.A
CLL Pharma S.A developer of generic drugs designed to offer galenical formulations.
Cotinga Pharmaceuticals
Cotinga Pharmaceuticals discovers and develops drug therapies for diseases.
Desitin Arzneimittel
Desitin Arzneimittel is a European pharmaceutical company specializes in products for the therapy of neurological and psychiatric diseases.
EntomoPharm
EntomoPharm, a biotechnology company, develops insect based screening models for predicting ADMET properties of chemical agents.
ICM - Brain & Spine Institute
ICM is a nonprofit translational neuroscience institute that researches about brain and spinal cord disorders.
Jakob and Partners
Jakob & Partners focuses on unbiased research and evidence-based analysis to support the pharma and biotech markets in business decisions.
Menarini
Besides Italy, where Menarini is one of the leading pharmaceutical groups, sales are mainly concentrated in Europe: Austria, Benelux,
OrganoBalance GmbH
OrganoBalance GmbH develops, produces, and markets medicines used in the treatment of dental and skin bacterial infections.
Orphinic Scientific
Orphinic Scientific focuses on orphan diseases and other diseases.
Orthomol
Orthomol develops and distributes products like orthomolecular nutritional medicines and immune boosters.
PanGenetics
PanGenetics B.V. develops monoclonal antibodies for the treatment of immune mediated diseases.
PaxVax
PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.
PDP Couriers
PDP Couriers is a truly global specialist courier for clinical trials, transport of clinical and medical research and logistics management.
Pharmasum Therapeutics
A pharmaceutical company developing drugs for autoimmune/metabolic and neurological diseases
Premas Biotech
Premas Biotech provides therapeutics and vaccines development apps, manufacturing, cell line, process and analytical development services.
Raritan Pharmaceuticals
Raritan Pharmaceuticals offers development and manufacturing of generic medicines, medical devices, cosmetics and consumer products.
SEPS Pharma
SEPS Pharma provides drug product development services, encompassing preformulation and formulation development.
Simbec-Orion Group
Simbec-Orion Group Provides Clinical Development Solutions.
SLA Pharma
SLA Pharma is a pharmaceutical company focused on developing medicines for the prevention and treatment of gastrointestinal disorders.
Solural Pharma
Solural Pharma uses its formulation technology platform to develop new innovative oral drug products that meet the need by the patients
Sterling Pharma Solutions
Sterling Pharma Solutions is a provider of small molecule API development and manufacturing services to the global pharmaceutical industry.
Targetrin Therapeutics
Targetrin Therapeutics develop novel drug candidates through the unique combination of industry leading novel cyclodextrin R&D and cGMP.
Torbay Pharmaceuticals
Torbay Pharmaceuticals specializes in the production of terminally sterilized injectable medicines and a range of oral liquids.
Current Employees Featured
Founder
Official Site Inspections
http://www.aoporphan.com
- Host name: ec2-3-121-55-139.eu-central-1.compute.amazonaws.com
- IP address: 3.121.55.139
- Location: Frankfurt am Main Germany
- Latitude: 50.1188
- Longitude: 8.6843
- Timezone: Europe/Berlin
- Postal: 60313
More informations about "AOP Orphan Pharmaceuticals" on Search Engine
AOP Health: Rebranding: AOP Orphan is now AOP Health
All of AOP Orphan’s business units and subsidiaries have now been united under the new AOP Health brand. Vienna, 20.01.2022. Previously known as AOP Orphan, AOP Health …See details»
AOP Health: New digital presence for international …
Mar 21, 2024 Allow all services. The international pharmaceutical company AOP Orphan Pharmaceuticals GmbH (AOP Health) has modernized its global web presence to …See details»
AOP Orphan: a European pioneer in the field of rare and complex …
Mar 12, 2021 Austria-based company AOP Orphan Pharmaceuticals AG has been working in the field of rare and complex diseases for 25 years, placing the needs of the …See details»
AOP Health: Rare disease pioneer AOP Orphan takes over two …
Oct 12, 2020 AOP Orphan Pharmaceuticals AG (AOP Orphan) took over the Viennese pharmaceutical company Amomed and the Luxembourgish health-tech company …See details»
AOP Health Receives Market Authorization for Landiolol …
Dec 13, 2023 VIENNA-- ( BUSINESS WIRE )-- At the end of November 2023, AOP Orphan Pharmaceuticals GmbH (AOP Health), an Austrian pharmaceutical company …See details»
Andreas Steiner, CEO of AOP Orphan Pharmaceuticals
Apr 29, 2021 Andreas Steiner, CEO of AOP Orphan Pharmaceuticals. Healthcare & Pharmaceutical. EMEA. Making an impact: Andreas Steiner. Out of all the patients with …See details»
AOP Health | LinkedIn
Previously known as AOP Orphan, AOP Health is the European pioneer for integrated therapies for rare diseases and in critical care.See details»
Blood Cancer: AOP Health Announces New Findings in Patients …
Sep 19, 2023 VIENNA-- ( BUSINESS WIRE )--AOP Orphan Pharmaceuticals GmbH (AOP Health) announced the publication of final results on the recently developed …See details»
AOP Orphan Pharmaceuticals - Crunchbase Company Profile
AOP Orphan Pharmaceuticals engages in developing, marketing, and distributing medicines for orphan indications and complex diseases. Vienna, Wien, Austria. 51-100. …See details»
Life Sciences Directory: AOP Orphan Pharmaceuticals AG
AOP Orphan Pharmaceuticals AG is an international pharmaceutical company with a focus on rare and special diseases. Over the past 25 years, the company has become …See details»
Orphanet: AOP Orphan Pharmaceuticals AG
Professionals and institution. Homepage > Professionals and institutions > Institutions. Search for an institution. AOP Orphan Pharmaceuticals AG. Wilhelminenstrasse 91/IIf. …See details»
Aop Orphan Pharmaceuticals GmbH - Drug pipelines, Patents, …
Aop Orphan Pharmaceuticals GmbH - Drug pipelines, Patents, Clinical trials - Synapse. Private Company |. 1996 |. Wien, Austria. |. 50-100. |. www.aoporphan.com. Last update …See details»
AOP Global Health - Crunchbase Investor Profile & Investments
Medical. Pharmaceutical. Headquarters Regions European Union (EU), Europe, Middle East, and Africa (EMEA) Founded Date 1996. Founders Widmann Rudolf. Operating …See details»
Organization | AOP Orphan Pharmaceuticals AG - CDEK
AOP Orphan Pharmaceuticals AG Report issue. For profit Phase 1 Phase 2 Phase 3. Founded: Vienna Austria (1996 ... Organization Overview. First Clinical Trial. 2000 …See details»
AOP Orphan Pharmaceuticals - Contacts, Employees, Board …
AOP Orphan Pharmaceuticals engages in developing, marketing, and distributing medicines for orphan indications and complex diseases.See details»
AOP Orphan and Amomed Pharma announce the launch of …
Jun 19, 2017 AOP Orphan Pharmaceuticals AG (AOP Orphan) today announced that RAPIBLOC® (Rapibloc, 300 mg powder for solution for infusion) will as of June 19th be …See details»
AOP Orphan Pharmaceuticals - Crunchbase
AOP Orphan Pharmaceuticals engages in developing, marketing, and distributing medicines for orphan indications and complex diseases.See details»
AOP Orphan Pharmaceuticals, GmbH. - Drug pipelines, Patents …
250-500. |. www.aop-health.com. Last update 01 Apr 2024. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & Funding (NIH) Investment. Financing. Overview. …See details»
AOP Orphan Pharmaceuticals - Tech Stack, Apps, Patents
Mar 31, 2024 About. AOP Orphan Pharmaceuticals uses 9 technology products and services including HTML5 , Microsoft Outlook , and Google Tag Manager, according to …See details»